Imidazolium Salts for Candida spp. Antibiofilm High-Density Polyethylene-Based Biomaterials.
Clarissa Martins Leal SchrekkerYuri Clemente Andrade SokoloviczMaria Grazia RaucciClaudio Alberto Martins LealLuigi AmbrosioMário Lettieri TeixeiraAlexandre Meneghello FuentefriaHenri Stephan SchrekkerPublished in: Polymers (2023)
The species of Candida present good capability to form fungal biofilms on polymeric surfaces and are related to several human diseases since many of the employed medical devices are designed using polymers, especially high-density polyethylene (HDPE). Herein, HDPE films containing 0; 0.125; 0.250 or 0.500 wt% of 1-hexadecyl-3-methylimidazolium chloride (C 16 MImCl) or its analog 1-hexadecyl-3-methylimidazolium methanesulfonate (C 16 MImMeS) were obtained by melt blending and posteriorly mechanically pressurized into films. This approach resulted in more flexible and less brittle films, which impeded the Candida albicans, C. parapsilosis , and C. tropicalis biofilm formation on their surfaces. The employed imidazolium salt (IS) concentrations did not present any significant cytotoxic effect, and the good cell adhesion/proliferation of human mesenchymal stem cells on the HDPE-IS films indicated good biocompatibility. These outcomes combined with the absence of microscopic lesions in pig skin after contact with HDPE-IS films demonstrated their potential as biomaterials for the development of effective medical device tools that reduce the risk of fungal infections.
Keyphrases
- biofilm formation
- candida albicans
- ionic liquid
- high density
- room temperature
- pseudomonas aeruginosa
- endothelial cells
- staphylococcus aureus
- mesenchymal stem cells
- escherichia coli
- carbon nanotubes
- induced pluripotent stem cells
- healthcare
- pluripotent stem cells
- stem cells
- drug delivery
- type diabetes
- tissue engineering
- soft tissue
- adipose tissue
- risk assessment
- bone regeneration